AVBP
ArriVent BioPharma, Inc. Common Stock
There isn't enough reported data to score AVBP yet.
AVBP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AVBP's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
AVBP PE Valuation
AVBP has no meaningful PE right now: it lost money over the past year.
AVBP Forward outlook
There aren't enough analyst estimates for AVBP to show an outlook.
AVBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.51 | +$0.72 |
| Q2 2026 | -$3.53 | +$0.48 |
| Q1 2026 | -$3.38 | +$0.38 |
| Q4 2025 | -$4.32 | -$1.76 |
| Q3 2025 | -$4.23 | -$1.64 |
| Q2 2025 | -$4.01 | -$1.60 |
| Q1 2025 | -$3.76 | -$1.36 |
| Q4 2024 | -$2.56 | -$0.50 |
AVBP lost $3.51 per share over the past year, a smaller loss than the year before.
AVBP Quarterly Revenue
AVBP's revenue is growing: $5M last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -868% | N/A |
AVBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$40.7M | -$4.9M |
| Q2 2026 | -$39.6M | -$13.5M |
| Q1 2026 | -$41.9M | +$26.1M |
| Q4 2025 | -$30.7M | -$14.5M |
| Q3 2025 | -$35.8M | -$19.5M |
| Q2 2025 | -$26.1M | -$7M |
| Q1 2025 | -$68M | -$49.4M |
| Q4 2024 | -$16.2M | -$1.2M |
AVBP has burned cash in almost every quarter: −$153M over the past year, against −$146M the year before.
AVBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +1.9M shares |
| 1 year | +18% | +7.6M shares |
| 3 years | +48% | +16M shares |
AVBP has 50M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
AVBP Net Leverage
AVBP's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AVBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 12.0 | Oversold |
AVBP's weekly RSI is 28 (oversold) and its Stochastic is 12 (oversold).
AVBP PE vs Healthcare Sector
AVBP has no meaningful PE right now: it lost money over the past year.
AVBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.1 | 32% below |
| 20 week MA | $26.2 | 50% below |
| 50 week MA | $25.8 | 49% below |
| 100 week MA | $23.7 | 45% below |
AVBP is in a downtrend: it's below all four of its weekly moving averages, and 45% below its 100-week average.
AVBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $20.0 | $27.3 | +36% |
| 2025 | $27.3 | $22.0 | -19% |
| 2026 YTD | $22.0 | $13.1 | -41% |
AVBP has finished lower in one of the last two years. It's down 41% so far in 2026.